Surgical Science Sweden AB (ST:SUS) — Stock Price

Skr38.12 SEK
▲ 2.75% today

Surgical Science Sweden AB (ST:SUS) is currently trading at Skr38.12 SEK, up 2.75% today. Over the past 52 weeks, shares have ranged between Skr23.92 and Skr107.80. This page tracks Surgical Science Sweden AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Surgical Science Sweden AB.

Surgical Science Sweden AB (SUS) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Surgical Science Sweden AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Surgical Science Sweden AB Income Statement — Revenue, Profit & Earnings by Year

Surgical Science Sweden AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr992.34 Million Skr884.09 Million Skr882.85 Million Skr802.54 Million Skr366.78 Million
Cost of Revenue Skr415.44 Million Skr286.19 Million Skr269.97 Million Skr271.02 Million Skr100.84 Million
Gross Profit Skr576.90 Million Skr597.90 Million Skr612.88 Million Skr531.52 Million Skr265.94 Million
Research & Development Skr191.41 Million Skr196.11 Million Skr181.65 Million Skr172.79 Million Skr65.71 Million
SG&A Skr276.50 Million Skr77.12 Million Skr72.51 Million Skr63.65 Million Skr66.04 Million
Total Operating Expenses Skr467.94 Million Skr453.58 Million Skr423.73 Million Skr368.98 Million Skr209.42 Million
Operating Income Skr108.97 Million Skr144.32 Million Skr189.15 Million Skr162.54 Million Skr88.75 Million
EBITDA Skr192.34 Million Skr224.29 Million Skr324.53 Million Skr271.30 Million Skr115.05 Million
EBIT Skr108.97 Million Skr163.77 Million Skr268.92 Million Skr227.66 Million Skr88.75 Million
Interest Expense Skr6.28 Million Skr5.68 Million Skr656.00K Skr1.30 Million Skr22.95 Million
Income Before Tax Skr100.14 Million Skr158.09 Million Skr268.26 Million Skr208.17 Million Skr65.80 Million
Income Tax Expense Skr33.32 Million Skr26.45 Million Skr34.29 Million Skr20.20 Million Skr-20.44 Million
Net Income Skr66.82 Million Skr131.65 Million Skr233.97 Million Skr187.97 Million Skr86.25 Million

Surgical Science Sweden AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Surgical Science Sweden AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr4.69 Billion Skr5.48 Billion Skr4.70 Billion Skr4.65 Billion Skr3.98 Billion
Total Current Assets Skr1.18 Billion Skr1.43 Billion Skr991.19 Million Skr826.37 Million Skr616.91 Million
Cash & Equivalents — — — Skr433.73 Million Skr316.68 Million
Short-term Investments — — — — —
Net Receivables Skr208.25 Million Skr258.14 Million Skr110.60 Million Skr244.12 Million Skr179.79 Million
Inventory Skr205.97 Million Skr179.58 Million Skr154.45 Million Skr134.88 Million Skr113.11 Million
Property, Plant & Equipment Skr106.35 Million Skr101.53 Million Skr76.62 Million Skr51.36 Million Skr38.39 Million
Goodwill Skr3.08 Billion Skr3.62 Billion Skr3.33 Billion Skr3.44 Billion Skr3.02 Billion
Total Liabilities Skr418.31 Million Skr651.03 Million Skr357.46 Million Skr413.11 Million Skr393.06 Million
Total Current Liabilities Skr291.14 Million Skr512.72 Million Skr234.94 Million Skr305.91 Million Skr232.38 Million
Long-term Debt Skr1.62 Million Skr235.41 Million — — Skr160.68 Million
Net Debt Skr-614.80 Million Skr-675.81 Million Skr-594.34 Million Skr-419.05 Million Skr-304.61 Million
Total Stockholder Equity Skr4.27 Billion Skr4.83 Billion Skr4.35 Billion Skr4.24 Billion Skr3.59 Billion
Retained Earnings Skr706.23 Million Skr639.41 Million Skr507.76 Million Skr273.79 Million Skr85.82 Million

Surgical Science Sweden AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Surgical Science Sweden AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr79.80 Million Skr137.22 Million Skr238.29 Million Skr129.49 Million Skr39.08 Million
Capital Expenditures Skr11.68 Million Skr47.53 Million Skr44.13 Million Skr34.55 Million Skr14.38 Million
Free Cash Flow Skr68.12 Million Skr89.69 Million Skr194.16 Million Skr94.94 Million Skr24.71 Million
Investing Cash Flow Skr-134.25 Million Skr-47.53 Million Skr-44.13 Million Skr-34.55 Million Skr-2.73 Billion
Financing Cash Flow Skr-259.68 Million Skr227.65 Million Skr15.85 Million Skr17.09 Million Skr2.92 Billion
Dividends Paid — — — — —
Stock-Based Compensation — — — — —
Depreciation Skr83.37 Million Skr60.51 Million Skr55.61 Million Skr51.59 Million Skr33.52 Million
Change in Cash Skr-351.73 Million Skr333.79 Million Skr200.63 Million Skr117.05 Million Skr229.52 Million

Surgical Science Sweden AB Earnings History — EPS Actual vs. Analyst Estimates

Track Surgical Science Sweden AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 20, 2026 — 0.29 —
Feb 19, 2026 0.69 0.85 -18.82%
Nov 13, 2025 0.40 0.73 -45.21%
Aug 21, 2025 -0.39 0.34 -214.71%
May 14, 2025 0.65 0.60 +8.33%
Feb 19, 2025 0.71 1.02 -30.39%
Nov 14, 2024 0.84 0.75 +12.00%
Aug 22, 2024 0.56 0.72 -22.22%